Tevis Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$573K Hold
20,400
0.33% 65
2025
Q4
$520K Hold
20,400
0.31% 75
2025
Q3
$520K Hold
20,400
0.31% 75
2025
Q2
$494K Hold
20,400
0.32% 77
2025
Q1
$541K Hold
20,400
0.4% 66
2024
Q4
$541K Hold
20,400
0.4% 66
2024
Q3
$590K Sell
20,400
-50
-0.2% -$1.46K 0.44% 62
2024
Q2
$572K Buy
20,450
+50
+0.2% +$1.38K 0.46% 59
2024
Q1
$566K Hold
20,400
0.48% 59
2023
Q4
$587K Hold
20,400
0.54% 55
2023
Q3
$677K Hold
20,400
0.69% 50
2023
Q2
$748K Hold
20,400
0.73% 46
2023
Q1
$832K Hold
20,400
0.85% 42
2022
Q4
$1.05M Sell
20,400
-745
-4% -$35.7K 1.11% 38
2022
Q3
$926K Buy
21,145
+7
+0% +$340 0.9% 40
2022
Q2
$1.11M Buy
21,138
+6
+0% +$306 1.06% 34
2022
Q1
$1.09M Sell
21,132
-30,515
-59% -$1.58M 0.99% 34
2021
Q4
$3.05M Buy
+51,647
New +$2.56M 2.66% 5

Other funds holding PFE

Tevis Investment Management's PFE Position: Q1 2026 in Review

Tevis Investment Management held its Pfizer (PFE) position steady in Q1 2026 at 20,400 shares worth $573K. The position accounts for 0.33% of the portfolio, ranked #65.

Tevis Investment Management first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.05M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Tevis Investment Management held 20,400 shares of Pfizer worth $573K as of Q1 2026.
  • Tevis Investment Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.33% of Tevis Investment Management's portfolio in Q1 2026, its #65 holding.
  • Tevis Investment Management first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
  • Tevis Investment Management's Pfizer position peaked at $3.05M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Tevis Investment Management's 13F filing for Q1 2026, filed 4 May 2026.